BioMendics
PrivateLast Round
Seed
Sep 4, 2016
Total Funding Raised
$25,000
Company Overview
BioMendics operates in Healthcare & Life Sciences and is based in Ohio. Its latest recorded funding round was a Seed round in September 2016.
BioMendics is a clinical-stage biotechnology company that develops innovative topical therapeutics for rare genetic and dermatologic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioMendics Comparables
Compare BioMendics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mariposa Therapeutics | 85% | |
| CSA Biotechnologies | 82% | |
| Aegle Therapeutics Corp | 80% |
For institutional investors. Book with your work email.
BioMendics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 4, 2016 | ||||
| Grant | Dec 10, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioMendics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 35% MoM.
- Jan 2, 2026
Monthly visitors increased 80% MoM.
For institutional investors. Book with your work email.
BioMendics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioMendics's valuation, stock price, and market status.
Is BioMendics a public or private company?
BioMendics is a private company.
What is the current stock price of BioMendics?
BioMendics is a private company, so its shares have no public market price. Caplight tracks BioMendics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioMendics worth (valuation)?
Valuation information for BioMendics is not publicly available.
Can I buy BioMendics stock?
BioMendics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioMendics's last funding round?
BioMendics's most recent funding round was Seed on September 4, 2016.
Who are the main investors in BioMendics?
Key investors in BioMendics include Innovation Fund.
Will BioMendics IPO soon?
No public IPO plans have been announced for BioMendics.
How can I track BioMendics secondary market activity?
Caplight tracks bids, offers, and trades in BioMendics's shares on secondary markets.